サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：疼痛管理デバイスの世界市場-2023年～2030年
市場調査レポート
商品コード
1297767

疼痛管理デバイスの世界市場-2023年～2030年

Global Pain Management Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
疼痛管理デバイスの世界市場-2023年～2030年
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

疼痛管理デバイスの世界市場は、2022年に37億米ドルに達し、2030年には63億米ドルに達するなど、有利な成長が予測されています。世界の疼痛管理デバイス市場は、予測期間中（2023-2030年）にCAGR 7.1％を示すと予測されています。

疼痛管理は、慢性疼痛患者の苦痛を和らげるのに役立つ医学の一分野です。急性の痛みは作用開始が早いことが知られているが、慢性の痛みは長期間続くことがあり、痛みの治療が必要となります。

世界の疼痛管理デバイス市場は、疼痛管理における技術の進歩や大規模な研究開発のエスカレート、ポイントオブケア検査に対する需要の増加、手術後の痛みの再発などにより、大きく成長しています。

市場力学

低侵襲手術への需要の高まりが疼痛管理デバイス市場の成長をさらに加速させる

外科手術に使用される疼痛管理デバイスは、患者の治療効果と満足度を高める。低侵襲手術で最もよく利用される疼痛管理技術には、患者管理鎮痛（PCA）ポンプ、経皮的電気神経刺激（TENS）ユニット、末梢神経ブロックなどがあります。例えば米国では、メディケア・メディケイド・サービスセンター（CMS）が、手術を受ける患者に対するオピオイドの使用を制限するため、代替疼痛管理法の使用を促進する規則を取り入れました。

疼痛管理デバイスの貧弱な入手可能性

いくつかの低所得地域では、疼痛治療器具の入手可能性が限られており、市場の成長を制限しています。WHOによると、55億人（世界人口の80％以上）が中等度から重度の疼痛治療薬を利用できないです。疼痛治療の障害には、疼痛緩和に対する理解や態度の欠如、薬剤の入手や使用（特にオピオイド）に関する課題などがあります。

COVID-19影響分析

疼痛管理デバイス市場はCOVID-19によって深刻な影響を受けたが、その背景には在宅ソリューションに対する需要の増加など多くの要因がある：移動の制約やヘルスケア施設へのアクセスが限られているため、在宅での疼痛治療が重視されています。このため、経皮的電気神経刺激（TENS）装置、温熱療法装置、携帯型超音波装置などの在宅疼痛治療製品に対する需要が高まっています。

遠隔医療と遠隔モニタリング：疫病の流行により、遠隔医療や遠隔モニタリング技術の利用が増加しました。バーチャル診察や遠隔モニタリング機器は、患者が自宅で慢性疼痛障害を治療するために利用されています。接続機能を備えた疼痛治療ガジェットが普及し、患者は離れた場所からヘルスケア専門家と話したり、支援を受けたりできるようになっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 肺動脈性肺高血圧症の有病率の増加
    • 抑制要因
      • 疼痛管理デバイスの治療に使用される薬剤の副作用
    • 機会
      • ジェネリック医薬品市場の急成長
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

  • 刺激型神経調節装置
  • 経皮的電気神経刺激（TENS）デバイス
  • 脊髄刺激（SCS）デバイス
  • アブレーション装置
    • 冷凍アブレーション装置
    • 高周波
  • 鎮痛輸液ポンプ
    • 髄腔内注入ポンプ
    • 体外式輸液ポンプ
  • その他

第8章 用途別

  • がん性疼痛
  • 筋骨格系疼痛
  • 片頭痛
  • 神経障害性疼痛
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第11章 企業プロファイル

  • Medtronic
  • Boston Scientific Corporation
  • Stryker
  • Stim Wave LLC
  • ICU Medical Inc
  • Johnson & Johnson Company
  • Baxter
  • Liva Nova
  • Abbott
  • DJO Global LLC

第12章 付録

目次
Product Code: MD329

Market Overview

The Global Pain Management Devices Market reached US$ 3.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.3 billion by 2030. The global pain management devices market is expected to exhibit a CAGR of 7.1% during the forecast period (2023-2030).

Pain management is a discipline of medical science that aids in the relief of chronic pain sufferers' suffering. Acute pain is known to have a fast beginning of action, however chronic pain may linger for a longer period of time, necessitating pain treatment.

The global pain management devices market is growing significantly due to escalating technological advancement and massive research and development in pain management, increasing demand for point-of-care testing, and the reappearance of pain after surgery.

Market Dynamics

The Growing Demand for Minimally Invasive Surgeries is Further Increasing the Pain Management Devices Market Growth

Pain management devices used in surgical operations increase patient results and satisfaction. Some of the most often utilized pain management technologies in minimally invasive operations include patient-controlled analgesia (PCA) pumps, transcutaneous electrical nerve stimulation (TENS) units, and peripheral nerve blocks. For instance, In United States, the Centers for Medicare and Medicaid Services (CMS) incorporated rules to promote the use of alternative pain management methods in order to limit the use of opioids for patients having surgery.

Poor Availability of Pain Management Devices

The availability of pain treatment devices is limited in several low-income locations, limiting market growth. According to WHO, 5.5 billion people (more than 80% of the world population) do not have access to moderate to severe pain remedies.2 The majority of these folks are from low- and middle-income nations. Some hurdles to pain treatment include a lack of understanding and attitudes about pain reduction, as well as challenges with drug access and use, particularly opioids.

COVID-19 Impact Analysis

Pain management devices market had severe impact by COVID-19 where numerous factors are the reason behind like Increased demand for home-based solutions: Because of movement constraints and limited access to healthcare facilities throughout the epidemic, there has been a greater emphasis on home-based pain treatment. This has raised demand for at-home pain treatment products such as transcutaneous electrical nerve stimulation (TENS) units, thermal therapy devices, and portable ultrasound machines.

Telemedicine and remote monitoring: The epidemic increased the use of telemedicine and remote monitoring technology. Virtual consultations and remote monitoring equipment have been used by patients to treat chronic pain disorders from home. Pain treatment gadgets with connection features have grown more popular, allowing patients to speak with healthcare specialists and receive help from a distance.

Segment Analysis

The global pain management devices market is segmented based on product type, application

The Musculoskeletal Pain Application Segment will be Dominated By Market Players During the Forecast Period.

During the forecast period, the musculoskeletal pain category is expected to retain a sizable proportion of 42.3%. The expanding ageing population and the increasing adoption of sedentary lifestyles are the primary causes of the rise in musculoskeletal discomfort among people. Patients and healthcare professionals are using a variety of solutions, including pain management devices, to address musculoskeletal pain, leading in segmental increase.

Geographical Analysis

North America is the Dominating Region During the Forecast Period accounting for around 39.8% of the Total Market Share

North America has dominated the market for pain treatment devices due to a huge patient pool, rising healthcare expenditure, and increased government financing and efforts.The market in the region is expanding rapidly, owing mostly to an ageing population, a drastic lifestyle connected with sickness, and neurological diseases.

For example, in 2021, an estimated 20.9% of U.S. adults (51.6 million people) had chronic pain, and 6.9% (17.1 million people) had high-impact chronic pain (i.e., chronic pain that limits daily activities significantly), with a higher prevalence among non-Hispanic American Indian or Alaska Native adults, adults who identified as bisexual, and adults who were divorced or separated.

Competitive Landscape

The major global players include: Stim Wave LLC, Baxter International, Inc., Boston Scientific Corp., ICU Medical Inc, Johnson & Johnson Company, DJO Global LLC, Liva Nova, Medtronic Plc, Smiths Medical, Abbott, and Stryker Corp.

Why Purchase the Report?

  • To visualize the global pain management devices market segmentation based on the product type, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global pain management devices market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global pain management devices market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in prevalence of pulmonary artery hypertension
    • 4.1.2. Restraints
      • 4.1.2.1. Side effects of the drug used for treating Pain Management Devices
    • 4.1.3. Opportunity
      • 4.1.3.1. Rapidly growing generic drug market
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion s of COVID-19

7. By Product Type

  • 7.1 Stimulated Neuromodulator Devices
  • 7.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 7.3 Spinal Cord Stimulation (SCS) Devices
  • 7.4 Ablation Devices
    • 7.1.1. Cryoablation Devices
    • 7.1.2. Radiofrequency
  • 7.5 Analgesia Infusion Pumps
    • 7.1.3. Intrathecal Infusion Pumps
    • 7.1.4. External Infusion Pumps
  • 7.6 Others

8. By Application

  • 8.1. Cancer Pain
  • 8.2. Musculoskeletal Pain
  • 8.3. Migraine
  • 8.4. Neuropathic Pain
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic
  • 11.2. Boston Scientific Corporation
  • 11.3. Stryker
  • 11.4. Stim Wave LLC
  • 11.5. ICU Medical Inc
  • 11.6. Johnson & Johnson Company
  • 11.7. Baxter
  • 11.8. Liva Nova
  • 11.9. Abbott
  • 11.10. DJO Global LLC

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us